pharma · Advanced Solid Tumors · Solid Tumor · PYXS
Pyxis Oncology
Pyxis Oncology clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2019
- Employees
- 71
- Programs
- 8
- Drugs
- 6
- Patents
- 3
Pyxis Oncology projects
8 ClinicalTrials.gov programs sponsored by Pyxis Oncology.
Pyxis Oncology has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
APX005M
Pyxis Oncology
Melanoma
1 trial -
PYX-201
Pyxis Oncology
Advanced Solid Tumors
1 trial -
PYX-201-102
Pyxis Oncology
Advanced Solid Tumors
1 trial -
PBTC-051
Pyxis Oncology
Glioblastoma Multiforme
1 trial -
PYX-106
Pyxis Oncology
Solid Tumor
1 trial -
PYX-201
Pyxis Oncology
Solid Tumor
1 trial -
Phase 1 Study of PYX-106 in Solid Tumors
Pyxis Oncology
Solid Tumors
1 trial -
Phase 1 Study of PYX-201 in Solid Tumors
Pyxis Oncology
Advanced solid tumors
1 trial
Frequently asked questions
How many clinical projects does Pyxis Oncology have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.